GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Noevir Holdings Co Ltd (TSE:4928) » Definitions » EV-to-EBIT

Noevir Holdings Co (TSE:4928) EV-to-EBIT : 13.52 (As of May. 23, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Noevir Holdings Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Noevir Holdings Co's Enterprise Value is 円154,688 Mil. Noevir Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was 円11,442 Mil. Therefore, Noevir Holdings Co's EV-to-EBIT for today is 13.52.

The historical rank and industry rank for Noevir Holdings Co's EV-to-EBIT or its related term are showing as below:

TSE:4928' s EV-to-EBIT Range Over the Past 10 Years
Min: 1.87   Med: 13.97   Max: 27.13
Current: 13.52

During the past 13 years, the highest EV-to-EBIT of Noevir Holdings Co was 27.13. The lowest was 1.87. And the median was 13.97.

TSE:4928's EV-to-EBIT is ranked better than
50.37% of 1485 companies
in the Consumer Packaged Goods industry
Industry Median: 13.75 vs TSE:4928: 13.52

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Noevir Holdings Co's Enterprise Value for the quarter that ended in Mar. 2024 was 円153,136 Mil. Noevir Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was 円11,442 Mil. Noevir Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 7.47%.


Noevir Holdings Co EV-to-EBIT Historical Data

The historical data trend for Noevir Holdings Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noevir Holdings Co EV-to-EBIT Chart

Noevir Holdings Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.62 17.37 17.80 16.37 13.89

Noevir Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.96 14.70 13.89 13.54 13.38

Competitive Comparison of Noevir Holdings Co's EV-to-EBIT

For the Household & Personal Products subindustry, Noevir Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Noevir Holdings Co's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Noevir Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Noevir Holdings Co's EV-to-EBIT falls into.



Noevir Holdings Co EV-to-EBIT Calculation

Noevir Holdings Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=154687.644/11442
=13.52

Noevir Holdings Co's current Enterprise Value is 円154,688 Mil.
Noevir Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円11,442 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noevir Holdings Co  (TSE:4928) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Noevir Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=11442/153136.012
=7.47 %

Noevir Holdings Co's Enterprise Value for the quarter that ended in Mar. 2024 was 円153,136 Mil.
Noevir Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円11,442 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noevir Holdings Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Noevir Holdings Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Noevir Holdings Co (TSE:4928) Business Description

Traded in Other Exchanges
N/A
Address
6-13-1 Minatojimanakamachi, Chuo-ku, Kobe, JPN, 650-8521
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses, cosmetics, and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces and sells a broad range of products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in a number of countries across the world, and focuses on developing Asian markets.

Noevir Holdings Co (TSE:4928) Headlines

No Headlines